Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meetings, 87943 [2016-29140]
Download as PDF
<![CDATA[
87943
Federal Register / Vol. 81, No. 234 / Tuesday, December 6, 2016 / Notices
stimulating factor-dependent
mechanism. Am J Respir Cell Mol Biol.
2012 Aug;47(2):186–95. [PMID
22427535]
8. Yao X, et al. 5A, an apolipoprotein A-I
mimetic peptide, attenuates the
induction of house dust mite-induced
asthma. J Immunol. 2011 Jan
1;186(1):576–83. [PMID 21115733]
9. Osei-Hwedieh DO, et al. Apolipoprotein
mimetic peptides: Mechanisms of action
as anti-atherogenic agents. Pharmacol
Ther. 2011 Apr;130(1):83–91. [PMID
21172387]
10. D’Souza W, et al. Structure/function
relationships of apolipoprotein a-I
mimetic peptides: implications for
antiatherogenic activities of high-density
lipoprotein. Circ Res. 2010 Jul
23;107(2):217–27. [PMID 20508181]
11. Amar MJ, et al. 5A apolipoprotein
mimetic peptide promotes cholesterol
efflux and reduces atherosclerosis in
mice. J Pharmacol Exp Ther. 2010
Aug;334(2):634–41. [PMID 20484557]
12. Tabet F, et al. The 5A apolipoprotein AI mimetic peptide displays
antiinflammatory and antioxidant
properties in vivo and in vitro.
Arterioscler Thromb Vasc Biol. 2010
Feb;30(2):246–52. [PMID 19965776]
13. Sethi AA, et al. Asymmetry in the lipid
affinity of bihelical amphipathic
peptides. A structural determinant for
the specificity of ABCA1–dependent
cholesterol efflux by peptides. J Biol
Chem. 2008 Nov 21;283(47):32273–82.
[PMID 18805791]
mstockstill on DSK3G9T082PROD with NOTICES
Intellectual Property: NIH Reference
No. E–114–2004/0—Issued Patents:
• US 7,572,771 issued 2009–11–08;
• US 8,071,746 issued 2011–12–06;
• US 8,148,323 issued 2012–04–03;
• US 8,835,378 issued 2014–09–16;
• AU 2005295640 issued 2011–11–10;
• CA 2584048 issued 2016–08–09;
• EP 1812474 issued 2010–05–26,
validated in CH, DE, ES, FR, GB and
IT; and
• JP 5,091,679 issued 2012–09–21.
Licensing Contact: Cristina
Thalhammer-Reyero, Ph.D., M.B.A.;
301–435–4507; thalhamc@mail.nih.gov.
Collaborative Research Opportunity:
The National Heart, Lung, and Blood
Institute is seeking statements of
capability or interest from parties
interested in collaborative research to
further develop, evaluate or
commercialize ApoA–1 mimetic
peptides. For collaboration
opportunities, please contact Denise
Crooks, Ph.D. at 301–435–0103 or
crooksd@nhlbi.nih.gov.
Dated: November 30, 2016.
Cristina Thalhammer-Reyero,
Senior Licensing and Patenting Manager,
Office of Technology Transfer and
Development, National Heart, Lung, and
Blood Institute.
[FR Doc. 2016–29151 Filed 12–5–16; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
17:39 Dec 05, 2016
Jkt 241001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; NICHD T35
Teleconference Review.
Date: February 6, 2017.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge 6710B, 6701B Rockledge Drive,
Bethesda, MD 20817 (Telephone Conference
Call).
Contact Person: Sherry L. Dupere, Ph.D.,
Chief, Scientific Review Branch, Scientific
Review Branch, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6710B Bethesda
Drive, 2221A, Bethesda, MD 20892, 301–
451–3415, duperes@mail.nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; NICHD Consortium
for Research on Pediatric Trauma and Injury
Prevention (R24).
Date: April 10, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Joanna Kubler-Kielb,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, 6710B Bethesda Drive,
Bethesda, MD 20892, 301–435–6916, kielbj@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
Dated: November 29, 2016.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–29140 Filed 12–5–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
Accreditation and Approval of Camin
Cargo Control, Inc., as a Commercial
Gauger and Laboratory
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: Notice of accreditation and
approval of Camin Cargo Control, Inc.,
as a commercial gauger and laboratory.
AGENCY:
Notice is hereby given,
pursuant to CBP regulations, that Camin
Cargo Control, Inc., has been approved
to gauge and accredited to test
petroleum and certain petroleum
products for customs purposes for the
next three years as of June 7, 2016.
DATES: Effective Dates: The
accreditation and approval of Camin
Cargo Control, Inc., as commercial
gauger and laboratory became effective
on June 7, 2016. The next triennial
inspection date will be scheduled for
June 2019.
FOR FURTHER INFORMATION CONTACT:
Approved Gauger and Accredited
Laboratories Manager, Laboratories and
Scientific Services Directorate, U.S.
Customs and Border Protection, 1300
Pennsylvania Avenue NW., Suite
1500N, Washington, DC 20229, tel. 202–
344–1060.
SUPPLEMENTARY INFORMATION: Notice is
hereby given pursuant to 19 CFR 151.12
and 19 CFR 151.13, that Camin Cargo
Control, Inc., 3001 SW. 3rd Ave., Suite
#8, Fort Lauderdale, FL 33315, has been
approved to gauge and accredited to test
petroleum and certain petroleum
products for customs purposes, in
accordance with the provisions of 19
CFR 151.12 and 19 CFR 151.13. Camin
Cargo Control, Inc., is approved for the
following gauging procedures for
petroleum and certain petroleum
products set forth by the American
Petroleum Institute (API):
SUMMARY:
API chapters
3 ...................
7 ...................
8 ...................
9 ...................
12 .................
17 .................
E:\FR\FM\06DEN1.SGM
06DEN1
Title
Tank gauging.
Temperature Determination.
Sampling.
Density Determination.
Calculations.
Maritime Measurements.
]]>Agencies
[Federal Register Volume 81, Number 234 (Tuesday, December 6, 2016)]
[Notices]
[Page 87943]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-29140]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health & Human
Development; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel; NICHD T35 Teleconference Review.
Date: February 6, 2017.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge 6710B, 6701B
Rockledge Drive, Bethesda, MD 20817 (Telephone Conference Call).
Contact Person: Sherry L. Dupere, Ph.D., Chief, Scientific
Review Branch, Scientific Review Branch, Eunice Kennedy Shriver
National Institute of Child Health and Human Development, NIH, 6710B
Bethesda Drive, 2221A, Bethesda, MD 20892, 301-451-3415,
duperes@mail.nih.gov.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel; NICHD Consortium for Research on
Pediatric Trauma and Injury Prevention (R24).
Date: April 10, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW., Washington, DC 20015.
Contact Person: Joanna Kubler-Kielb, Scientific Review Officer,
Scientific Review Branch, Eunice Kennedy Shriver National Institute
of Child Health and Human Development, 6710B Bethesda Drive,
Bethesda, MD 20892, 301-435-6916, kielbj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.864,
Population Research; 93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation Research; 93.209,
Contraception and Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: November 29, 2016.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-29140 Filed 12-5-16; 8:45 am]
BILLING CODE 4140-01-P
